PSA screening for prostate cancer: new guidelines emphasize weighing harms and benefits
on June 7, 2013 at 10:04
- Tweet
Recent Posts
- Instrument calibration: vital first step for accurate results or just another clinical lab job?
- British Society of Immunology (BSI) Conference Highlights
- NCRI Cancer Conference: Event Highlights
- IL-6 and IL-18 Important in Rapid Cycling Bipolar Disorder
- BRAF melanoma cells secrete factors that activate stromal fibroblasts
Popular Posts
- RIQAS (Randox International Quality Assessment Scheme) gain accreditation to ISO/IEC 17043
5 comments - Lab Automation: A Necessity
5 comments - FDA Launches Medical Device Innovation Initiative
3 comments - New discovery closes in on genetic link between Alzheimer's and diabetes
2 comments - Confidante® a revolutionary new sexual health test from Randox Laboratories
2 comments - Inflammatory biomarker levels may be associated with increased risk of macular edema
2 comments - Pathologists and Clinical Labs Can Expect to See More Companion Diagnostic Tests
2 comments - PSA screening for prostate cancer: new guidelines
2 comments - Fast Growth in Molecular Diagnostics
2 comments - Innovation in the NHS at The Healthcare Innovation Expo 2011
2 comments
